Comprehensive medication guide to Hemady including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$100 copay depending on plan tier and deductible status; prior authorization required by most plans. Commercially insured patients can apply the Hemady Patient Savings Program to reduce copay to $0. Medicare Part D covers Hemady with a $2,100 annual out-of-pocket cap in 2026.
Estimated Cash Pricing
$240–$710+ retail for brand Hemady (no generic available at 20mg); as low as $240 with a GoodRx coupon, or $228 with GoodRx Gold. Commercially insured patients may pay $0 with the Hemady Patient Savings Program.
Medfinder Findability Score
50/100
Summarize with AI
On this page
Hemady is the brand name for dexamethasone 20 mg oral tablets, manufactured by Edenbridge Pharmaceuticals, LLC. It was FDA-approved in 2019 and is the only dexamethasone formulation specifically indicated for use in combination with other anti-myeloma products to treat adults with multiple myeloma.
The key innovation of Hemady is its high-strength 20 mg tablet. Before Hemady, patients needed five to ten 4 mg generic dexamethasone tablets per dose — Hemady reduces this to one or two tablets, cutting pill burden by up to 80%. Dexamethasone is a cornerstone of virtually all primary multiple myeloma treatment regimens, working both as a direct anti-myeloma agent and as an enhancer of other anti-myeloma drugs.
As of 2026, no FDA-approved generic version of Hemady at the 20 mg tablet strength exists. Hemady is a brand-only specialty medication dispensed through specialty pharmacies and hospital pharmacies affiliated with cancer centers.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Hemady (dexamethasone) is a synthetic glucocorticoid that works by binding to glucocorticoid receptors (GRs) inside multiple myeloma cells. This binding triggers programmed cell death (apoptosis) and inhibits myeloma cell proliferation in a dose-dependent manner — higher doses cause more myeloma cell death.
Dexamethasone also suppresses pro-inflammatory cytokines (like interleukin-6) that support myeloma cell survival in the bone marrow microenvironment. Equally important, dexamethasone enhances the activity of virtually every other anti-myeloma agent it is combined with — making the overall treatment regimen significantly more effective than any single drug alone.
Hemady has been demonstrated to be bioequivalent to previously available dexamethasone products, confirming that its pharmacokinetic profile is identical to generic dexamethasone. The advantage is purely convenience: fewer tablets, same therapeutic effect.
20 mg — tablet
Standard Hemady tablet strength; 1 tablet = 20mg dose; 2 tablets = 40mg dose (most common myeloma dose)
40 mg (2 tablets) — tablet
Most commonly prescribed dose for multiple myeloma — 2 × 20mg Hemady tablets taken once weekly on a designated day per treatment regimen
20 mg (1 tablet) — tablet
Lower dose used in some regimens or for elderly patients where dose reduction is indicated
Hemady is not in an official FDA drug shortage as of 2026, but many patients experience real access difficulties. The core challenge is distribution: Hemady is a specialty oncology medication dispensed exclusively through specialty pharmacies (CVS Specialty, Walgreens Specialty, Accredo, Biologics by McKesson, Optum Specialty) and hospital pharmacies connected to cancer centers. Standard retail pharmacies do not stock it.
Additionally, most insurance plans require prior authorization for Hemady, which can add days to weeks of delay if not initiated at the time of prescribing. Patients who take their prescription to a retail pharmacy or who don't have a prior authorization in place frequently experience what feels like a shortage — but is actually a structural access problem that can be resolved with the right approach.
To find Hemady in stock near you, start with your oncology team's preferred specialty pharmacy, or use medfinder — a service that calls pharmacies near you to check which ones can fill your Hemady prescription, then texts you the results.
Hemady is not a controlled substance and has no DEA scheduling restrictions, so any licensed prescriber with prescribing authority can write a prescription. However, because Hemady is specifically indicated for multiple myeloma combination therapy, it is almost exclusively prescribed by hematology-oncology specialists who are managing the patient's myeloma treatment.
Telehealth follow-up appointments with established oncology patients may allow for Hemady prescription management, but the initial multiple myeloma diagnosis and treatment planning require in-person oncology care. NCI-designated cancer centers and major academic medical centers have dedicated myeloma programs with the most experienced specialists.
No. Hemady (dexamethasone) is not a controlled substance and is not DEA-scheduled. Corticosteroids are not subject to the same prescribing restrictions as controlled substances such as opioids or stimulants. There are no refill limitations based on DEA scheduling.
The primary administrative hurdle for Hemady patients is insurance prior authorization — not controlled substance regulations. Your oncologist can prescribe Hemady through standard (non-controlled) prescribing procedures, and specialty pharmacies can typically accept electronic prescriptions. Refills are managed through standard pharmacy procedures and PA renewal timelines.
Common side effects of Hemady (dexamethasone) include:
Serious side effects requiring immediate medical attention:
Know what you need? Skip the search.
Dexamethasone 4mg tablets (generic)
Same active ingredient as Hemady. Requires 5–10 tablets per dose (vs. 1–2 Hemady tablets). Clinically equivalent at correct dose. Available at all retail pharmacies for $5–$15/month. Widely used as a cost-effective bridge when Hemady is unavailable or unaffordable.
Dexamethasone oral solution (Dexamethasone Intensol)
Liquid formulation (1 mg/mL) useful for patients with swallowing difficulties or GI issues. Requires dose calculation. Not FDA-approved specifically for myeloma like Hemady, but contains identical active ingredient.
Prednisone
Corticosteroid occasionally substituted in specific clinical situations (dexamethasone intolerance, liver impairment, elderly/frail patients). Not equivalent on a milligram-for-milligram basis — conversion requires careful calculation. Myeloma clinical evidence base is built on dexamethasone, not prednisone; substitution is not routine.
Compounded dexamethasone
Compounding pharmacies can prepare custom dexamethasone formulations (e.g., different strengths, suspension, suppository). Not FDA-approved at compounded strength but contains same active ingredient. Useful when standard formulations are inaccessible or patient has specific formulation needs.
Prefer Hemady? We can find it.
Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin)
majorIncrease dexamethasone blood levels, increasing risk of corticosteroid side effects including hyperglycemia, adrenal suppression, and Cushing's syndrome. Avoid concomitant use or adjust dose with oncologist guidance.
Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St. John's Wort)
majorDecrease dexamethasone blood levels, potentially reducing its anti-myeloma efficacy. Avoid concomitant use. St. John's Wort (herbal) is a common but often overlooked inducer.
Immunomodulatory drugs (thalidomide, lenalidomide, pomalidomide) + Hemady
majorCombination significantly increases risk of venous and arterial thromboembolism. Anticoagulation prophylaxis is standard when combining these agents. Monitor for signs of blood clot.
Carfilzomib (Kyprolis)
majorCombination with Hemady increases thromboembolism and cardiovascular risk. Anticoagulation typically prescribed. Monitor cardiac status.
NSAIDs (ibuprofen, naproxen)
majorCombination increases risk of GI bleeding, stomach ulcers, and GI perforation. Avoid if possible; use acetaminophen for pain relief instead. If NSAIDs required, gastroprotection (PPI) is recommended.
Erythropoiesis-stimulating agents (epoetin alfa, darbepoetin)
moderateFurther increases thromboembolism risk when used with Hemady and IMiDs in myeloma treatment. Use with caution; ensure adequate anticoagulation prophylaxis.
Estrogen-containing therapies (oral contraceptives, HRT)
moderateIncreases thromboembolism risk. Women requiring contraception should use non-estrogen methods (progestin-only, barrier methods) while on Hemady.
Warfarin (Coumadin)
moderateDexamethasone can alter anticoagulant effect — INR may increase or decrease. Monitor INR more frequently when starting or stopping Hemady. Do not self-adjust warfarin dose.
Diabetes medications (insulin, metformin, sulfonylureas)
moderateDexamethasone raises blood glucose, requiring temporary adjustments to diabetes medications on dex dosing days. Work with endocrinologist or PCP to create a glucose management plan.
Live vaccines (MMR, varicella, live flu mist)
majorAvoid live vaccines during immunosuppressive dexamethasone therapy. Inactivated vaccines (flu shot, Shingrix, COVID-19) are generally safe but immune response may be reduced.
Hemady represents an important quality-of-life improvement for multiple myeloma patients by reducing the pill burden of corticosteroid therapy — a cornerstone of all primary myeloma treatment regimens. Its FDA approval in 2019 as the first and only dexamethasone formulation specifically indicated for myeloma combination therapy reflects the clinical significance of optimizing how patients receive their therapy.
The main challenges with Hemady are access and cost — not clinical efficacy. As a brand-only specialty medication without a generic equivalent, Hemady requires specialty pharmacy channels, insurance prior authorization, and cost management strategies that many patients navigate without adequate guidance. The Hemady Patient Savings Program can reduce costs to $0 for commercially insured patients, and generic dexamethasone 4 mg tablets remain a clinically acceptable alternative when Hemady is unavailable or unaffordable.
If you're struggling to find Hemady at a pharmacy near you, medfinder calls pharmacies in your area to check which can fill your prescription and texts you the results — saving you hours of phone calls and helping ensure your myeloma treatment stays on track.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini